Trials / Completed
CompletedNCT06972134
Synergistic Effects of Natural Oils and Herbal Extracts on Cholesterol Gallstone Dissolution: In Vitro Comparison With Rowachol®
Synergistic Effects of Sesame Oil, Extra Virgin Olive Oil, Psyllium Extract, and Dandelion Extract on Cholesterol Gallstone Dissolution: An In Vitro Comparative Study Against Rowachol®
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- University of Duhok · Academic / Other
- Sex
- All
- Age
- 40 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Objective: This study aims to evaluate the effectiveness of a natural mixture (sesame oil, extra virgin olive oil, psyllium extract, and dandelion extract) in dissolving cholesterol gallstones compared to the standard medication, Rowachol®. Methods: In laboratory experiments, 70 cholesterol gallstones obtained from 55 patients were divided into seven groups. Each group was treated with different combinations of the natural ingredients or Rowachol®. The stones were monitored for 144 hours to measure dissolution rate and cholesterol release.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Sesame Oil (SO) at 100 mg/mL in dissolving fluid. | Pure Sesamum indicum oil (cold-pressed, unrefined) dissolved in BioIVT bile juice at 100 mg/mL. Prepared by homogenization (30 min, 37°C). Used as monotherapy. |
| DIETARY_SUPPLEMENT | Extra Virgin Olive Oil (EVOO) at 100 mg/mL in dissolving fluid. | Pure Olea europaea oil (first cold-pressed, acidity ≤0.8%) dissolved in BioIVT bile juice at 100 mg/mL. Prepared by vortex mixing (15 min, 25°C). Used as monotherapy. |
| DIETARY_SUPPLEMENT | 50% Sesame Oil (SO) + 50% Extra Virgin Olive Oil (EVOO). | A 1:1 (v/v) blend of Sesamum indicum oil (AIU-BC-618-1) and Olea europaea oil (AIU-BC-618-2). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by mechanical stirring (1 hr, 40°C). |
| DIETARY_SUPPLEMENT | 50% Psyllium Extract (PE) + 50% Oil Blend (50% SO + 50% EVOO). | 50% Plantago ovata mucilage extract (aqueous extraction, 65°C) + 50% AIU-BC-618-3 (SO+EVOO blend). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by sonication (20 min). |
| DIETARY_SUPPLEMENT | Plantago ovata extract (AIU-BC-618-4) + AIU-BC-618-3 | 50% Taraxacum officinale root extract (ethanol-water extraction, 70°C) + 50% AIU-BC-618-3 (SO+EVOO blend). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by magnetic stirring (30 min, 50°C). |
| DIETARY_SUPPLEMENT | 50% Herbal Extract (25% PE + 25% DE) + 50% Oil Blend (25% SO + 25% EVOO). | 25% Plantago ovata extract (AIU-BC-618-4) + 25% Taraxacum officinale extract (AIU-BC-618-5) + 25% SO (AIU-BC-618-1) + 25% EVOO (AIU-BC-618-2). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by homogenization (45 min, 37°C). |
| DRUG | Drug: Rowachol® (terpene extract) at 100 mg/mL in dissolving fluid. | 25% Plantago ovata extract (AIU-BC-618-4) + 25% Taraxacum officinale extract (AIU-BC-618-5) + 25% SO (AIU-BC-618-1) + 25% EVOO (AIU-BC-618-2). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by homogenization (45 min, 37°C). |
Timeline
- Start date
- 2023-12-15
- Primary completion
- 2024-05-17
- Completion
- 2024-08-28
- First posted
- 2025-05-14
- Last updated
- 2025-05-18
Locations
1 site across 1 country: Syria
Source: ClinicalTrials.gov record NCT06972134. Inclusion in this directory is not an endorsement.